EUVIMEDEUVIMED entdecken
Crossref

Hypersensitivity to adrenomedullin in post-traumatic headache: a randomized crossover study

Haidar M Al-Khazali, Zahra Hakimzadeh, Anna G Melchior, Berkay Alpay, Ksenija Cucanić, Annette M Fuchs, Messoud Ashina, Håkan Ashina iD

Brain · 13.11.2026

DOI: 10.1093/brain/awag401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 13.11.2026. Verfasst von Haidar M Al-Khazali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Discoveries in Migraine and Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, 2600 Copenha….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adrenomedullin (ADM), a vasoactive member of the calcitonin peptide family with receptor-signalling overlap with calcitonin gene-related peptide (CGRP), has emerged as a candidate therapeutic target in migraine. Given the striking clinical parallels between migraine and persistent post-traumatic headache (PTH), we investigated whether ADM-responsive signalling contributes to migraine-like headache in adults with persistent PTH attributed to mild traumatic brain injury. We conducted a single-centre, randomised, double-blind, placebo-controlled, two-way crossover study in adults with persistent PTH and no pre-trauma history of migraine. On two experimental days separated by at least 7 days, participants received 20-minute intravenous infusions of ADM (19.9 pmol kg⁻¹ min⁻¹) and isotonic saline as the matched inactive comparator (placebo) in randomised sequence. Headache outcomes were recorded for 12 hours. The primary outcome was the within-participant incidence of experimentally induced migraine-like headache. The secondary outcome was the within-participant difference in baseline-corrected area under the curve (AUC) for headache intensity from 0 to 12 hours. Of 158 individuals assessed for eligibility, 21 were randomised, completed both periods and were analysed. Participants had a mean age of 34.3 years, 19 (90%) were female, and 18 (86%) reported a migraine-like phenotype. Migraine-like headache occurred in 17 of 21 participants (81%) after ADM and four of 21 (19%) following placebo. Fourteen participants developed migraine-like only after ADM and one only following placebo, yielding a paired absolute risk difference of 61.9 percentage points (95% CI 29.7–80.6; one-sided P < 0.001; two-sided P = 0.001). Baseline-corrected headache-intensity AUC was higher after ADM than placebo (median 1,110 [IQR 315–2205] versus 420 [−160 to 565]; P = 0.006). Median time to onset of migraine-like headache was 30 minutes after ADM and 390 minutes following placebo. Fifteen participants reported that the ADM-induced headache resembled their usual migraine-like headache episodes, and rescue medication was used by 10 participants after ADM and two after placebo. These findings identify pronounced responsiveness to ADM-linked signalling in persistent PTH and support the ADM pathway as a candidate target for mechanism-based therapeutic development, pending confirmation in independent cohorts and complementary preclinical studies.

Schlagwörter

Stichwörter der Autor:innen

adrenomedullinmigrainepost-traumatic headachetrigeminovascular system

Autor:innen und Institutionen

  • Department of Neurology, Center for Discoveries in Migraine and Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, 2600 Copenhagen, Denmark.
  • Translational Research Center, Copenhagen University Hospital - Rigshospitalet, 2600 Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Danish National Knowledge Center on Headache Disorders, Copenhagen University Hospital - Rigshospitalet, 2600 Copenhagen, Denmark.
  • Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.

ORCID-Profile: Håkan Ashina

Zitieren

APA

Al-Khazali, H. M., Hakimzadeh, Z., Melchior, A. G., Alpay, B., Cucanić, K., Fuchs, A. M., Ashina, M., & Ashina, H. (2026). Hypersensitivity to adrenomedullin in post-traumatic headache: a randomized crossover study. Brain. https://doi.org/10.1093/brain/awag401

Vancouver

Al-Khazali HM, Hakimzadeh Z, Melchior AG, Alpay B, Cucanić K, Fuchs AM, et al. Hypersensitivity to adrenomedullin in post-traumatic headache: a randomized crossover study. Brain. 2026. doi:10.1093/brain/awag401

BibTeX
@article{AlKhazali2026,
  author = {Al-Khazali, Haidar M and Hakimzadeh, Zahra and Melchior, Anna G and Alpay, Berkay and Cucanić, Ksenija and Fuchs, Annette M and Ashina, Messoud and Ashina, Håkan},
  title = {Hypersensitivity to adrenomedullin in post-traumatic headache: a randomized crossover study},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag401}
}
Kostenlos starten →